AJO, LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
AJO, LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$4,463,000
+2572.5%
46,826
+2823.0%
0.05%
+4600.0%
Q4 2019$167,000
-99.1%
1,602
-99.2%
0.00%
-99.1%
Q3 2019$19,384,000
-12.1%
194,743
+0.9%
0.11%
-1.8%
Q2 2019$22,040,000
-18.9%
193,077
-10.6%
0.11%
-18.6%
Q1 2019$27,163,000
-23.3%
216,075
-17.2%
0.14%
-29.6%
Q4 2018$35,411,000
-51.2%
260,952
-1.2%
0.20%
-42.0%
Q3 2018$72,493,000
+15.7%
264,100
-12.6%
0.34%
+18.7%
Q2 2018$62,634,000
+19.7%
302,330
-4.5%
0.29%
+20.4%
Q1 2018$52,306,000
+230.8%
316,696
+174.3%
0.24%
+252.9%
Q4 2017$15,810,000
+204.5%
115,461
+202.8%
0.07%
+195.7%
Q3 2017$5,192,000
+523.3%
38,131
+455.4%
0.02%
+475.0%
Q2 2017$833,000
-91.6%
6,865
-92.6%
0.00%
-90.2%
Q1 2017$9,871,000
+94.5%
93,267
+86.7%
0.04%
+95.2%
Q4 2016$5,076,000
-59.4%
49,952
-59.2%
0.02%
-60.4%
Q3 2016$12,489,000
-74.9%
122,366
-70.6%
0.05%
-76.0%
Q2 2016$49,681,000
-22.7%
416,546
-30.6%
0.22%
-20.5%
Q1 2016$64,234,000
+214.1%
599,815
+218.0%
0.28%
+212.4%
Q4 2015$20,447,000
+481.4%
188,594
+359.2%
0.09%
+456.2%
Q3 2015$3,517,000
+1.9%
41,066
+20.1%
0.02%
+6.7%
Q2 2015$3,450,00034,1900.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders